Cerevance
Rob previously served as CFO of Envoy Therapeutics and as Chief Corporate Development Officer of Perlegen Sciences. Earlier, Rob held a number of senior leadership roles with Fidelity Investments including Chief Investment Officer of the $28 billion Managed Income Group and Head Trader of the $26 billion Municipal Money Market Group.
This person is not in any offices